Company: Solarvest Bioenergy Inc.
Listing : TSX Venture,Frankfurt
Ticker: SVS.V , 0ZJ:FRA
Market cap at time of publication: $18.26 MCAD
Stock price at time of publication: $0.33 CAD
Business: Patented plant based pharmaceuticals from algaes and Clean Energy Hydrogen production
Comparable peers: Else Nutrition market cap : 306 MCAD
Website:http://www.solarvest.ca/ and for the omega 3 products: https://eversea.ca/
We are pleased to see Solarvest announce that its subsidiary, Eversea Inc., has entered into a contractual agreement with Canada’s Smartest Kitchen to develop a formulation for a nutritional-enhancing ingredient based on Eversea’s patented organic DHA powder. This mixture can be used by companies who are producing plant-based seafoods which require Omega-3s to compete in the fish and shellfish marketplace. Canada’s Smartest Kitchen’s expertise in food science, ingredients and flavours makes it the perfect partner to help develop this new product(s).
Gerri Greenham (CEO) comments: This is an exciting opportunity for the company, to use its
unique and patented organic Omega-3 ingredient for the plant-based fish and meat industry, as
consumers of plant-based seafood are looking for a healthy, environmentally-friendly product.
Eversea has developed a fish-free, algae-based organic Omega-3 that has been certified organic
by the EU and USDA. The product does not contain any chemicals, and it has received
Glyphosate Residue Free certification from The Detox Project.
ESG comments:
We are pleased to see Solarvest Bioenergy is continuing to deliver on their growth plans. The company’s organic Omega 3 products is the world’s first and only organic Omega 3. You can find our initial analysis of the company here – https://esgfireat40.com/2021/04/05/a-hidden-gem-in-the-clean-energy-booming-plant-based-sector/
Legal Disclaimer:
We own shares of this company personally.
Investing in stocks is combined with certain risks and it is possible to lose your entire investment. My posts are made for Educational purposes only and are not to be interpreted as tips , financial advise or recommendations of any kind to either buy or sell any stocks.
Companies may or may not be paying us for content posted on this blog.
